OptimizeRx insider uses 1,381 shares for option and tax costs

OptimizeRx Corp (OPRX) reported an insider Form 4 for Edward Stelmakh, Chief Finance & Strat Officer.

Rhea-AI Filing Summary

OptimizeRx Corp (OPRX) reported an insider Form 4 for Edward Stelmakh, Chief Finance & Strat Officer. On 2026-08-21, 1,381 shares of common stock were disposed of under code F at $7.71 per share, representing shares delivered or withheld for payment of exercise price or tax liability. Following this transaction, Stelmakh’s reported direct holdings total 121,791 shares of OptimizeRx common stock. A footnote states that the filing should not be construed as an admission of beneficial ownership or that the filing is legally required.

Insider Trade Summary

Exercise Price or Tax Liability: 1,381 shares

Exercise Price or Tax Liability 1 txn

Insider Stelmakh Edward

Role Chief Finance & Strat Officer

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock F1	1,381	$7.71	$11K

Holdings After Transaction: Common Stock — 121,791 shares (Direct)

Footnotes (1)

1. F1. The filing of this Statement shall not be construed as an admission (a) that the person filing this Statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this Statement, or (b) that this Statement is legally required to be filed by such person.

Key Figures

Shares delivered/withheld (code F): 1,381 shares of Common Stock Price per share: $7.71 per share Shares owned after transaction: 121,791 shares of Common Stock

3 metrics

Shares delivered/withheld (code F) 1,381 shares of Common Stock Disposition on 2026-08-21 for payment of exercise price or tax liability

Price per share $7.71 per share Value reported for the 1,381-share code F transaction on 2026-08-21

Shares owned after transaction 121,791 shares of Common Stock Direct holdings reported for Edward Stelmakh following the transaction

Key Terms

Payment of exercise price or tax liability by delivering or withholding securities, beneficial owner, Section 16 of the Securities Exchange Act of 1934

3 terms

Payment of exercise price or tax liability by delivering or withholding securities financial

"transaction coded F indicates payment of exercise price or tax liability"

beneficial owner regulatory

"shall not be construed as an admission ... is the beneficial owner"

A beneficial owner is the person who ultimately owns or controls a financial asset or property, even if their name isn't directly on official documents. Think of it like someone who secretly holds the keys to a safe deposit box—others may appear to have access, but the true owner is the one who benefits from what's inside. Identifying beneficial owners helps ensure transparency and prevent illegal activities like money laundering or fraud.

Section 16 of the Securities Exchange Act of 1934 regulatory

"for the purposes of Section 16 of the Securities Exchange Act of 1934"

A provision of federal securities law that requires company insiders—directors, officers and large shareholders—to publicly report their stock holdings and trades and to surrender any “short-swing” profits from purchases and sales within a six-month window. It acts like a rule that forces leaders to announce their trades and prevents quick buy-sell windfalls, giving investors transparency into insider activity and reducing opportunities for unfair gain.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did OptimizeRx (OPRX) disclose for Edward Stelmakh?

OptimizeRx disclosed that Edward Stelmakh, Chief Finance & Strat Officer, had 1,381 shares of common stock disposed of on 2026-08-21 under code F, with shares delivered or withheld for payment of exercise price or tax liability.

At what price were the OptimizeRx (OPRX) shares valued in the Form 4 transaction?

The 1,381 OptimizeRx common shares in the Form 4 transaction were reported at $7.71 per share, with the transaction coded F, indicating payment of exercise price or tax liability by delivering or withholding securities.

How many OptimizeRx (OPRX) shares does Edward Stelmakh hold after this Form 4 transaction?

After the reported transaction, Edward Stelmakh’s direct holdings total 121,791 shares of OptimizeRx common stock, as stated in the Form 4 filing.

What does transaction code F mean in the OptimizeRx (OPRX) Form 4 for Edward Stelmakh?

In this Form 4, code F means payment of exercise price or tax liability by delivering or withholding securities. The 1,381 shares were disposed of for this purpose, rather than as an open-market sale.

Does the OptimizeRx (OPRX) Form 4 admit that Edward Stelmakh is the beneficial owner of the shares?

No. A footnote states the filing should not be construed as an admission that Edward Stelmakh is the beneficial owner of any equity securities covered or that the filing is legally required.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/24/2026 - 03:12 PM EDT Accepted by SEC EDGAR 08/24/2026 - 03:11 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Stelmakh Edward

(Last) (First) (Middle)

C/O OPTIMIZERX CORPORATION

260 CHARLES STREET, SUITE 302

(Street)

WALTHAM MASSACHUSETTS 02453

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
OptimizeRx Corp [ OPRX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Finance & Strat Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/21/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/21/2026		F		1,381(1)	D	$7.71	121,791	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The filing of this Statement shall not be construed as an admission (a) that the person filing this Statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this Statement, or (b) that this Statement is legally required to be filed by such person.

Remarks:

The filing of this Statement shall not be construed as an admission (a) that the person filing this Statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this Statement, or (b) that this Statement is legally required to be filed by such person.

	/s/ Marion Odence-Ford, by Power of Attorney	08/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)